AI cybersecurity is a cat and mouse gamejust now Russia to require content made by, with AI to be labeled as such — GFCN president2h ago Flipkart’s Super.money Bets on AI Agents to Outdo Bigger Rivals2h ago Datasette 1.0a39 and 0.65.4 security releases2h ago Anthropic caught scientists using Claude to further biological weapon research3h ago Oracle says AI will save it from the SaaSpocalypse, not bring it on3h ago Congress Is Suddenly Waking Up to the AI Doomsday Threat4h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself4h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers4h ago Introducing ChatGPT for Financial Services4h ago Tesla unveils driverless Cybercab in Japan for 1st time5h ago The AI safety vibe shift5h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.5h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff5h ago

AI cybersecurity is a cat and mouse gamejust now Russia to require content made by, with AI to be labeled as such — GFCN president2h ago Flipkart’s Super.money Bets on AI Agents to Outdo Bigger Rivals2h ago Datasette 1.0a39 and 0.65.4 security releases2h ago Anthropic caught scientists using Claude to further biological weapon research3h ago Oracle says AI will save it from the SaaSpocalypse, not bring it on3h ago Congress Is Suddenly Waking Up to the AI Doomsday Threat4h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself4h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers4h ago Introducing ChatGPT for Financial Services4h ago Tesla unveils driverless Cybercab in Japan for 1st time5h ago The AI safety vibe shift5h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.5h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff5h ago

Healthcare AI Research4 min reading time

Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist and Patient Data

Unite.AIPublished 9 days ago

Owkin has licensed its AI Scientist platform K Pro and multimodal oncology and immunology patient data to Boehringer Ingelheim to accelerate biopharma research. The deal builds on a 2025 pilot using Owkin's MOSAIC spatial multiomics cancer dataset. Boehringer's teams will use K Pro to analyze data and generate hypotheses in oncology and immunology research.

#biopharma-research #boehringer-ingelheim #k-pro #mosaic #oncology-datasets #owkin #spatial-multiomics

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes11h ago

Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch8h ago

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources1d ago